These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10067276)
1. Synthesis of a new class of HIV-1 inhibitors. Farese-Di Giorgio A; Pairot S; Patino N; Condom R; Di Giorgio C; Aumelas A; Aubertin AM; Guedj R Nucleosides Nucleotides; 1999 Feb; 18(2):263-75. PubMed ID: 10067276 [TBL] [Abstract][Full Text] [Related]
5. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots". Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049 [TBL] [Abstract][Full Text] [Related]
6. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Wu F; Garcia J; Sigman D; Gaynor R Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997 [TBL] [Abstract][Full Text] [Related]
7. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2. García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754 [TBL] [Abstract][Full Text] [Related]
8. A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription. Das I; Désiré J; Manvar D; Baussanne I; Pandey VN; Décout JL J Med Chem; 2012 Jul; 55(13):6021-32. PubMed ID: 22698070 [TBL] [Abstract][Full Text] [Related]
9. Interaction of new PNA-based molecules with TAR RNA of HIV-1: molecular modelling and biological evaluation. Terreux R; Pairot S; Cabrol-Bass D; Patino N; Condom R J Mol Graph Model; 2001; 19(6):579-85, 614-5. PubMed ID: 11552687 [TBL] [Abstract][Full Text] [Related]
10. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system. Xie B; Calabro V; Wainberg MA; Frankel AD J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301 [TBL] [Abstract][Full Text] [Related]
11. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production. Kaushik N; Basu A; Palumbo P; Myers RL; Pandey VN J Virol; 2002 Apr; 76(8):3881-91. PubMed ID: 11907228 [TBL] [Abstract][Full Text] [Related]
12. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening. Du Z; Lind KE; James TL Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782 [TBL] [Abstract][Full Text] [Related]
13. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA. Long KS; Crothers DM Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630 [TBL] [Abstract][Full Text] [Related]
14. Blocking HIV replication by targeting Tat protein. Hamy F; Gelus N; Zeller M; Lazdins JL; Bailly C; Klimkait T Chem Biol; 2000 Sep; 7(9):669-76. PubMed ID: 10980447 [TBL] [Abstract][Full Text] [Related]
15. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033 [TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967 [TBL] [Abstract][Full Text] [Related]
17. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease. Jayasena SD; Johnston BH Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures. Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1. Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274 [TBL] [Abstract][Full Text] [Related]